BIO KEY INTERNATIONAL INC 10-Q

ITEM 5. OTHER INFORMATION During the three months ended June 30, 2025 , none of our directors or “officers” (as defined in Rule 16a - 1 (f) under the Securities Exchange Act of 1934, as amended) adopted or terminated a “Rule 10b5 - 1 trading arrangement” or “non-Rule 10b5 - 1 trading arrangement,” as each term is defined in Item 408 of Securities and Exchange Commission Regulation S-K. ITEM 6. EXHIBITS Exhibit No. Description 31.1 Certificate of CEO of Registrant required under Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended 31.2 Certificate of CFO of Registrant required under Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended 32.1 Certificate of CEO of Registrant required under 18 U.S.C. Section 1350 32.2 Certificate of CFO of Registrant required under 18 U.S.C. Section 1350 101.INS Inline XBRL Instance 101.SCH Inline XBRL Taxonomy Extension Schema 101.CAL Inline XBRL Taxonomy Extension Calculation 101.DEF Inline XBRL Taxonomy Extension Definition 101.LAB Inline XBRL Taxonomy Extension Labels 101.PRE Inline XBRL Taxonomy Extension Presentation 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). 24 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIO-Key International, Inc. Dated: August 13, 2025 /s/ Michael W. DePasquale Michael W. DePasquale Chief Executive Officer (Principal Executive Officer) Dated: August 13, 2025 /s/ Cecilia C. Welch Cecilia C. Welch Chief Financial Officer (Principal Financial Officer) 25